Pricing Log in Create free account
Friday 6 November 2026 Export CRL’s income statement to Excel — free account

Charles River Laboratories International, Inc.

CRL Healthcare Diagnostics & Research

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024.

Revenue
−2.20%
EPS
+530.3%
Free cash flow
+16.3%
Total debt
+11.8%

Quarter to September 2026, against a year earlier

336.85 23.83 +7.61%
Market cap
$14.9B
P/E
322×
Fwd P/E
89.2×
Dividend yield
—
F-score
5/9
Altman Z
2.40
Beneish M
−3.11
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Charles River Laboratories International, Inc. (CRL) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, Charles River Laboratories International, Inc. (CRL) trades at a EV/Sales of 4.6×. Over the past ten years it has ranged from 1.8× (April 2025) to 7.8× (September 2021); the current reading is higher than 86% of that period. That is below the Diagnostics & Research industry median of 5.2× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.9× 3.30%
FY2024 2.8× (18.19%)
FY2023 3.5× 1.96%
FY2022 3.4× (43.55%)
FY2021 6.0× 25.12%
FY2020 4.8× 39.31%
FY2019 3.5× 13.96%
FY2018 3.0× (9.30%)
FY2017 3.4× 19.69%
FY2016 2.8× (14.72%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 4.1× 23.41%
Jun 2026 3.3× 22.87%
Mar 2026 2.7× (7.84%)
Dec 2025 2.9× 22.27%
43 more quarters

Against its own ten years

Low 1.8× High 7.8×
Ten-year median 3.3×
Current reading's percentile 84

EV/Sales against peers

Company EV/Sales
ICLR ICON PLC compare 2.4×
LH Labcorp Holdings Inc. compare 2.4×
DGX Quest Diagnostics Incorporated compare 2.8×
CRL Charles River Laboratories International, Inc. 4.3×
QGEN QIAGEN N.V. compare 5.4×
MEDP Medpace Holdings, Inc. compare 6.0×
RVTY Revvity Inc. compare 6.6×
ILMN Illumina, Inc. compare 7.2×
GH Guardant Health, Inc. compare 16.6×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on CRL